Acadia Healthcare (NASDAQ:ACHC – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
Other analysts have also issued reports about the stock. Barclays reduced their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. Royal Bank of Canada decreased their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. KeyCorp assumed coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price target for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $75.44.
Read Our Latest Stock Analysis on ACHC
Acadia Healthcare Trading Down 1.2 %
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the prior year, the firm posted $0.91 earnings per share. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. Equities research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Acadia Healthcare
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Blue Trust Inc. lifted its position in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth about $59,000. Covestor Ltd increased its holdings in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after acquiring an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare during the third quarter worth approximately $86,000.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- Insider Buying Explained: What Investors Need to Know
- Micron Stock Under $100: Seize the AI-Driven Upside
- What is a Death Cross in Stocks?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Overbought Stocks Explained: Should You Trade Them?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.